title: Amino acid imbalance early in septic encephalopathy.
abstract: OBJECTIVE
  To evaluate plasma amino acid concentrations and markers of inflammation in the early stage and the course of septic encephalopathy.
  
  
  METHODS
  Prospective, case series of patients with well-defined septic encephalopathy.
  
  
  METHODS
  Surgical department and intensive care unit of a university hospital.
  
  
  METHODS
  Seventeen patients with sepsis according to the ACCP/SCCM consensus conference criteria and encephalopathy based on neuropsychological tests, compared to a control group undergoing uncomplicated thoracic surgery.
  
  
  METHODS
  None.
  
  
  RESULTS
  SOFA score, blood samples for plasma amino acids, procalcitonin and interleukin-6. Sepsis was determined to be the cause of encephalopathy in 14 of the 17 patients. Six patients developed septic shock, four died within the study period of 28 days. Within 12 h of the onset of septic encephalopathy, mean values of PCT and IL-6 were elevated ( p<0.001) and the amino acids unbalanced (the ratio of branched-chain to aromatic amino acids was decreased, p<0.001). During the course of sepsis the decreased amino acid ratio was significantly, but moderately, correlated with elevated PCT and IL-6 levels. On study days when PCT was higher than 2 ng/ml, the amino acid ratio was significantly lower. In no patient was severe liver dysfunction seen.
  
  
  CONCLUSIONS
  Metabolic disturbances with changes in amino acid levels can occur early in septic patients, without serious liver abnormalities. The present data suggest a possible role of amino acids in the pathogenesis of septic encephalopathy.
authors.affiliation: Klinik für Anaesthesiologie und Intensivtherapie, University Hospital, Bachstrasse 18, 07743 Jena, Germany.
authors.forename: Thomas
authors.initials: T
authors.lastname: Basler
authors.forename: Andreas
authors.initials: A
authors.lastname: Meier-Hellmann
authors.forename: Don
authors.initials: D
authors.lastname: Bredle
authors.forename: Konrad
authors.initials: K
authors.lastname: Reinhart
mesh_terms: D000596:Amino Acids / Q000097:blood*; D015415:Biomarkers; D001928:Brain Diseases, Metabolic / Q000097:blood*; D002116:Calcitonin / Q000097:blood; D015740:Calcitonin Gene-Related Peptide; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007249:Inflammation / Q000097:blood; D007362:Intensive Care Units; D015850:Interleukin-6 / Q000097:blood; D008099:Liver / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000097:blood*; D011446:Prospective Studies; D011498:Protein Precursors / Q000097:blood; D018805:Sepsis / Q000097:blood* / Q000175:diagnosis
chemical_list: D000596:Amino Acids; D015415:Biomarkers; C000606589:CALCA protein, human; D015850:Interleukin-6; D011498:Protein Precursors; D002116:Calcitonin; D015740:Calcitonin Gene-Related Peptide